Jiangsu Apon Medical Technology Co Ltd

Jiangsu Apon Medical Technology Co Ltd has a market price of 25.73 CNY per share, with a market capitalization of 3,243,215,040 CNY. The company's price-to-book ratio is 4.86, and its price-to-tangible-book ratio is also 4.86, indicating a premium valuation relative to its book value. The enterprise value to EBITDA ratio is negative at -124.49, reflecting the company's current operating losses. The enterprise value to revenue ratio is 9.83, suggesting a moderate valuation relative to its revenue. The company's profitability metrics are concerning, with a return on equity of -3.6% and a return on assets of -2.79%, both significantly below the industry median for medical equipment and supplies companies. The company reported a net loss of 24,020,680 CNY and an operating loss of 27,004,720 CNY, indicating a challenging operating environment. The gross profit margin is 67.7%, which is relatively high but insufficient to offset the company's operating expenses. Jiangsu Apon Medical Technology Co Ltd's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. The company's total revenue for the period is 342,017,500 CNY, with no segment-specific revenue breakdown provided. The lack of geographic and segment diversification increases the company's exposure to regional and product-specific risks. The company's growth trajectory is uncertain, with no specific revenue growth projections provided in the outlook. The company's operating cash flow is 2,332,920 CNY, and its free cash flow is negative at -23,996,510 CNY, indicating a cash outflow from operations after capital expenditures. The capital expenditure for the period is -8,434,740 CNY, suggesting ongoing investment in the business. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of concern is the negative net cash position after subtracting total debt, which could impact the company's ability to meet short-term obligations. The company's debt-to-equity ratio is 0.18, indicating a relatively low level of leverage. The current ratio of 2.59 suggests the company has sufficient current assets to cover its current liabilities. There are no recent events or filings mentioned in the provided data that would significantly impact the company's operations or financial position. The company's financial performance and risk profile suggest a need for close monitoring of its liquidity and profitability trends.